[1] |
World Health Organizationg. Global tuberculosis report 2019. Geneva:World Health Organization, 2019.
|
[2] |
Tesfahuneygn G, Medhin G, Legesse M. Adherence to Anti-tuberculosis treatment and treatment outcomes among tuberculosis patients in Alamata District, northeast Ethiopia. BMC Res Notes, 2015,8:503. doi: 10.1186/s13104-015-1452-x.
|
[3] |
World Health Organization. Guidelines for treatment of drug-susceptible tuberculosis and patient care. Geneva: World Health Organization, 2017.
|
[4] |
Hou WL, Song FJ, Zhang NX, et al. Implementation and community involvement in DOTS strategy: a systematic review of studies in China. Int J Tuberc Lung Dis, 2012,16:1433-1440. doi: 10.5588/ijtld.12.0080.
|
[5] |
World Health Organization. Handbook for the use of digital technologies to support tuberculosis medication adherence. Geneva: World Health Organization, 2017.
|
[6] |
Liu X, Lewis JJ, Zhang H, et al. Effectiveness of Electronic Reminders to Improve Medication Adherence in Tuberculosis Patients: A Cluster-Randomized Trial. PLoS Med, 2015,12:e1001876. doi: 10.1371/journal.pmed.1001876.
|
[7] |
桓世彤, 陈嵘, 刘小秋, 等. 电子药盒取药记录监测肺结核患者服药行为的可行性评估. 中国防痨杂志, 2012,34(7):419-424.
|
[8] |
Liu X, Blaschke T, Thomas B, et al. Usability of a Medication Event Reminder Monitor System (MERM) by Providers and Patients to Improve Adherence in the Management of Tuberculosis. Int J Env Res Public Heal, 2017,14: pii: E1115. doi: 10.3390/ijerph14101115.
|
[9] |
Wang N, Zhang H, Zhou Y, et al. Using electronic medication monitoring to guide differential management of tuberculosis patients at the community level in China. BMC Infect Dis, 2019,19:844. doi: 10.1186/s12879-019-4521-2.
|
[10] |
李智, 周惠, 陈晓军, 等. 基于数字技术的结核病患者管理方法研究进展. 中国防痨杂志, 2019,41(9):1015-1020. doi: 10.3969/j.issn.1000-6621.2019.09.019.
|
[11] |
Vrijens B, Urquhart J, White D. Electronically monitored dosing histories can be used to develop a medication-taking habit and manage patient adherence. Expert Rev Clin Pharmacol, 2014,7:633-644. doi: 10.1586/17512433.2014.940896.
|
[12] |
Xu W, Lu W, Zhou Y, et al. Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study. BMC Heal Serv Res, 2009,9:169. doi: 10.1186/1472-6963-9-169.
|
[13] |
Yao S, Huang WH, van den Hof S, et al. Treatment adherence among sputum smear-positive pulmonary tuberculosis patients in mountainous areas in China. BMC Health Serv Res, 2011,11:341. doi: 10.1186/1472-6963-11-341.
|
[14] |
Xu M, Markström U, Lyu J, et al. Detection of Low Adherence in Rural Tuberculosis Patients in China: Application of Morisky Medication Adherence Scale. Int J Environ Res Public Health, 2017,11:E248. doi: 10.3390/ijerph14030248.
|
[15] |
Demonceau J, Ruppar T, Kristanto P, et al. Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic literature review and meta-analysis. Drugs, 2013,73:545-562. doi: 10.1007/s40265-013-0041-3.
|
[16] |
Thakkar D, Piparva KG, Lakkad SG. A pilot project: 99DOTS information communication technology-based approach for tuberculosis treatment in Rajkot district. Lung India, 2019,36(2):108-111. doi: 10.4103/lungindia.lungindia_86_18.
|